Becton Dickinson (NYSE:BDX) received FDA clearance for its Surgiphor 1000mL antimicrobial irrigation system, expanding its surgical solutions portfolio. The company also launched the BD Vacutainer ...

Surgiphor 1,000mL allows clinicians to remove debris and microorganisms from wounds during powered irrigation procedures.

Becton, Dickinson and Company's ( NYSE:BDX ) investors are due to receive a payment of $1.05 per share on 31st ...

BD (Becton, Dickinson and Company) announced it has obtained CE Mark approval for the Revello vascular covered stent for the ...

We came across a bullish thesis on Becton, Dickinson and Company on X.com by @MoneyShow. In this article, we will summarize ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has received CE Mark approval in the European Union for its Revello Vascular Covered Stent. With this approval, BD ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has obtained ...

Becton Dickinson & Co. closed 7.01% short of its 52-week high of $187.35, which the company achieved on February 24th.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Becton, Dickinson, and Company (BDX), based in Franklin Lakes, New Jersey, is a leading global medical technology firm dedicated to advancing healthcare through innovative medical devices, laboratory ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 Index rose 10 ...

Business: Becton Dickinson develops, manufactures and sells medical supplies, devices, laboratory equipment and diagnostic products for health-care institutions, physicians, life science researchers, ...